Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers
Gregory C McDermott(Brigham and Women's Hospital), Jeffrey A. Sparks(Brigham and Women's Hospital), Elizabeth A. Regan(National Jewish Health), Zachary S. Wallace(Amgen (United States)), Michael H. Cho(Brigham and Women's Hospital), Gary M. Hunninghake(Hubei University of Science and Technology), Samuel Y. Ash(Pulmonary and Critical Care Associates), Edwin K. Silverman(Brigham and Women's Hospital), Kazuki Yoshida(Brigham and Women's Hospital), Tracy J. Doyle(Brigham and Women's Hospital), George R. Washko(Brigham and Women's Hospital), Paul F. Dellaripa(Brigham and Women's Hospital), Keigo Hayashi(Brigham and Women's Hospital), Matthew Moll(Brigham and Women's Hospital), Raúl San Jośe Estépar(Brigham and Women's Hospital), Pierre‐Antoine Juge(Inserm), Gregory L. Kinney(Colorado School of Public Health)
Cited by 10
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2010|986